Table 3.
Shows phytochemical compounds and their role in cancer therapies.
| Plant Name | Phytochemicals | Role in Cancer Therapy | Reference |
|---|---|---|---|
| Nigella sativa | Thymoquinone | Targets the signal transducer and activator of transcription factor 3 (STAT3) pathway thereby leading to the inhibition of cancer cell proliferation. | [20] |
| Petroselinum crispum | Apigenin | Targets intrinsic apoptotic pathways. In lung cancer, apigenin exert its effects by modulating signals between Akt and Snail/Slung signaling pathways leading to metastatic restrain of cancer cells. | [21] |
| Zingiber officianale | 6-Shogaol | Targets Akt and signal transducer and activator of transcription (STAT) signaling pathways. In NSCLC, 6-Shogaol directly regulates Akt1/2 pathways, which will in turn lead to the growth inhibition or induce apoptotic cell death. | [22] |
| Thymus vulgaris | Thymol | Targets the mitochondria and its effects induce mitochondrial malfunction and apoptosis of cancer cells. | [23] |
| Scutellaria baicalensis | Baicalein | Targets mitogen-activated protein kinase (MARPK), extracellular signal-regulated kinase (ERK), and p38 signaling pathways. In colon cancer, Baicalin induces apoptosis and growth suppression. | [24,25] |
| Glycyrrhiza glabra | Glycyrrhizin | Targets thromboxane A2 (TxA2) and signal transducer and activator of transcription (STAT) pathways. | [26] |
| Oldenlandia diffusa | Ursolic acid | Targets and interferes with cancer protein Ki-67, CD31, and microRNA 29 (miR-29a). | [27] |
| Melilotus officinalis | Dicumarol | Targets pyruvate dehydrogenase kinase 1 (PDK1) leading to the interference of the intrinsic apoptotic pathway | [28] |
| Glycyrrhiza glabra | Licochalcone A | Targets cyclins and cyclin-dependent kinases (CDKs). Their interaction with the cyclins and CDKs results in cell cycle arrest in the G0 or G1 and G2 or Mitotic phases. | [29] |